Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
10–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is able to provide written assent and the parents or legal guardian of the patient are/is able to provide written informed consent before beginning any study related procedures
Patient previously enrolled in either double-blind Study D1441C00149 or D1441C00112
Patient has documented clinical diagnosis of schizophrenia or bipolar I disorder
Patient's parent or legal guardian will be able to accompany the patient to each scheduled study visit
You may not be if
Patients (female) must not be pregnant or lactating
Patients with a known intolerance or lack of response to previous treatment with quetiapine
Patients who have previously participated in this study
